By Alex Harding, Entrepreneur-in-Residence at Atlas Venture, as part of the From The Trenches feature of LifeSciVC What will and will not work to regain US strength in phase 1 clinical trials “I don’t know anyone who runs their phase

By Abbas Kazimi, CEO of Nimbus Therapeutics, as part of the From The Trenches feature of LifeSciVC The Japanese Zen term shoshin means “beginner’s mind”. It’s the discipline of approaching familiar territory with fresh eyes and openness to see what

By Julia Pian, Senior Associate at Atlas Venture, as part of the From The Trenches feature of LifeSciVC Before attending my first board meeting, I fondly remember imagining a board as the “Room Where It Happens,” yearningly described by Aaron

By Aimee Raleigh, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC In most companies I am fortunate to be a part of, there is a strong relationship between investors and operators. But every so

By Arthur Tzianabos, CEO of Lifordi Immunotherapeutics, as part of the From The Trenches feature of LifeSciVC We work in a serious business — endeavoring to make people’s lives better and, in some cases, literally saving lives. It is a

The rise of China in the global biopharma ecosystem has led to fear and hysteria in some corners of our ecosystem.  Apparently there have been too many deals with Chinese players by both venture investors and Big Pharma. US biotech

By Abbas Kazimi, CEO of Nimbus Therapeutics, as part of the From The Trenches feature of LifeSciVC There’s a version of leadership that presents cleanly from the outside: the presence in the room, the confidence behind decisions, the sense of

By Aimee Raleigh, Principal at Atlas Venture, as part of the From The Trenches feature of LifeSciVC “Travel makes one modest. You see what a tiny place you occupy in the world.” — Gustave Flaubert Life sciences in April 2026

By Linda Bain, Venture Partner at Atlas Venture, as part of the From The Trenches feature of LifeSciVC “Do one thing every day that scares you” – Eleanor Roosevelt I remember the first time I consciously stepped out of my

By Julia Pian, Senior Associate at Atlas Venture, as part of the From The Trenches features of LifeSciVC As Jonathan Larson beautifully explores in “Seasons of Love” from Rent, it’s almost impossible to find the right variables to capture life

By Eric Green, CEO of Trace Neuroscience, as part of the From The Trenches feature of LifeSciVC Few neurodegenerative diseases have clearer genetic causation than Huntington’s disease (HD). And yet for decades, translating that genetic clarity into desperately needed effective

An IPO remains one of the most sought-after brass rings on the startup carousel, viewed as an important milestone on a biotech’s journey and a major financing event for powering up an emerging company.  It’s also one of the most